₹296.80-2.50 (-0.84%)
04:01 PM, 20-Feb-2025₹296.20-5.65 (-1.87%)
03:50 PM, 20-Feb-2025BSE : 540025
NSE : ADVENZYMES
Sector : Health care
ISIN Code : INE837H01020
Last Updated: 20-Feb-2025 | 10:31 AM IST
Market Cap (₹ Cr) | 3,321 |
Traded Value (₹ Cr) | 0.55 |
Volume (Shares) | 18,614 |
Face Value (₹) | 2 |
52-Week High (₹) | 571.15 |
52-Week High Date | 16-Sep-2024 |
52-Week Low (₹) | 292.00 |
52-Week Low Date | 20-Feb-2025 |
All Time High (₹) | 571.15 |
All Time High Date | 16-Sep-2024 |
All Time Low (₹) | 91.05 |
All Time Low Date | 23-Mar-2020 |
PARAMETER | VALUES |
---|---|
Market Cap (₹ Cr) | 3,314 |
EPS - TTM (₹) [C] | 12.79 |
P/E Ratio (X) [C] | 23.16 |
Face Value (₹) | 2 |
Latest Dividend (%) | 55.00 |
Latest Dividend Date | 18-Jul-2024 |
Dividend Yield (%) | 1.72 |
Book Value Share (₹) [C] | 119.92 |
P/B Ratio (₹) [C] | 2.47 |
Scheme Name | Amount Invested (₹ Cr) | No Of Shares | Net Asset (%) |
---|---|---|---|
ICICI Pru P.H.D Fund (IDCW) | 69.65 | 21,12,383 | 1.42 |
ICICI Pru P.H.D Fund (G) | 69.65 | 21,12,383 | 1.42 |
ICICI Pru P.H.D Fund - Direct (G) | 69.65 | 21,12,383 | 1.42 |
ICICI Pru P.H.D Fund - Direct (IDCW) | 69.65 | 21,12,383 | 1.42 |
UTI-MNC Fund (G) | 32.97 | 10,00,000 | 1.18 |
UTI-MNC Fund (IDCW) | 32.97 | 10,00,000 | 1.18 |
UTI-MNC Fund - Direct (IDCW) | 32.97 | 10,00,000 | 1.18 |
UTI-MNC Fund - Direct (G) | 32.97 | 10,00,000 | 1.18 |
ICICI Pru ESG Exclusionary Strategy Fund-Dir (G) | 28.75 | 8,72,022 | 1.95 |
ICICI Pru ESG Exclusionary Strategy Fund-Dir (IDCW) | 28.75 | 8,72,022 | 1.95 |
Load more
Date | Broker | Action | Prices(₹) | Report |
---|---|---|---|---|
Data Not Found |
Today's Low/High (₹) | 291.95 303.85 |
Week Low/High (₹) | 291.95 317.00 |
Month Low/High (₹) | 291.95 351.00 |
Year Low/High (₹) | 291.95 571.00 |
All time Low/High (₹) | 91.05 571.00 |
Period | BSE | NSE | SENSEX | NIFTY |
---|---|---|---|---|
1 Week | -4.22% | -4.13% | -0.53% | -0.51% |
1 Month | -12.88% | -12.97% | -1.74% | -1.85% |
3 Month | -21.65% | -21.60% | -2.37% | -2.57% |
6 Month | -35.31% | -35.35% | -6.27% | -7.23% |
1 Year | -26.06% | -26.22% | 3.67% | 3.23% |
3 Year | -0.24% | -0.30% | 30.96% | 32.63% |
Whole-time director : MUKUND MADHUSUDAN KABRA
Chairman (Non-Executive) : VASANT RATHI
Independent Director : Pramod Kasat
Company Sec. & Compli. Officer : Sanjay Basantani
Non-Exec & Non-Independent Dir : Rasika Rathi
Independent Director : Vindokumar Hiralal Jajoo
Non-Exec & Non-Independent Dir : Sunny Sharma
Independent Director : Rajshree Patel
Independent Director : NITIN JAGANNATH DESHMUKH
Independent Director : Vandana Tilak.
Registered Office: Sun Magnetica 5th Floor, Nr LIC Serivce Road Louiswadi,Thane,Maharashtra-400604 Ph: 91-22-41703200
1. What's the Advanced Enzyme Technologies Ltd share price today?
Advanced Enzyme Technologies Ltd share price was Rs 296.80 at 04:01 PM IST on 20th Feb 2025. Advanced Enzyme Technologies Ltd share price was down by 0.84% from the previous closing price of Rs 299.30. Advanced Enzyme Technologies Ltd share price trend:
2. How can I quickly analyse the performance of the Advanced Enzyme Technologies Ltd stock?
The performance of the Advanced Enzyme Technologies Ltd stock can be quickly analysed on the following metrics:
3. What is the market cap of Advanced Enzyme Technologies Ltd?
Advanced Enzyme Technologies Ltd has a market capitalisation of Rs 3,321 crore.
4. What is Advanced Enzyme Technologies Ltd's 52-week high/low share price?
The Advanced Enzyme Technologies Ltd’s 52-week high share price is Rs 571.15 and 52-week low share price is Rs 292.00.
5. Is the Advanced Enzyme Technologies Ltd profitable?
On a consolidated basis, Advanced Enzyme Technologies Ltd reported a profit of Rs 15.18 crore on a total income of Rs 102.30 crore for the quarter ended 2024. For the year ended Dec 2024, Advanced Enzyme Technologies Ltd had posted a profit of Rs 38.88 crore on a total income of Rs 176.80 crore.
6. Which are Advanced Enzyme Technologies Ltd’s peers in the Health care sector?
Advanced Enzyme Technologies Ltd’s top 5 peers in the Health care sector are Gufic BioScience, Aarti Drugs, Dishman Carbogen, Advanced Enzyme, Morepen Labs., Guj. Themis Bio., Senores Pharma..
7. Who owns how much in Advanced Enzyme Technologies Ltd?
Key changes to the Advanced Enzyme Technologies Ltd shareholding are as follows: